Author

Desmarini Desmarini

The University of SydneyORCID 0000-0001-9322-3198Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Dilipkumar UrediiD· 1 shared Hundaol Huluka· 1 shared Julianne T. DjordjeviciD· 1 shared Lucia E. RamehiD· 1 shared Michael A. Stashko· 1 shared Pratima Chapagain· 1 shared Raymond D. BlindiD· 1 shared Xiaodong WangiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

Dilipkumar UrediORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Design, synthesis and cellular characterization of a new class of IPMK kinase inhibitors

Yubai Zhou, Pratima Chapagain, Desmarini Desmarini, Dilipkumar Uredi, Michael A. Stashko, Hundaol Huluka, Lucia E. Rameh, Julianne T. Djordjevic, Raymond D. Blind, Xiaodong Wang

This study designs, synthesizes, and characterizes a new class of IPMK kinase inhibitors, showing reduced glioblastoma cell growth and a novel InsP5 metabolic signature.

Journal of Medicinal Chemistry · Jul 25, 2025Peer-reviewedPharmacology & Toxicology